Cargando…

Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents

A ligand-based and docking-based virtual screening was carried out to identify novel MDM2 inhibitors. A pharmacophore model with four features was used for virtual screening, followed by molecular docking. Seventeen compounds were selected for an in vitro MDM2 inhibition assay, and compounds AO-476/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bing-Hui, Ge, Jun-Qi, Wang, Ya-Li, Wang, Li-Jun, Zhang, Qi, Bian, Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369186/ https://www.ncbi.nlm.nih.gov/pubmed/34413896 http://dx.doi.org/10.1155/2021/3195957

Ejemplares similares

Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2
por: Houston, Douglas R., et al.
Publicado: (2015)

Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents
por: Vázquez-Jiménez, Lenci K., et al.
Publicado: (2022)

Salinomycin as a potent anticancer stem cell agent: State of the art and future directions
por: Qi, Dan, et al.
Publicado: (2021)

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents
por: Michalak, Olga, et al.
Publicado: (2023)

Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents
por: Afifi, Tarek H., et al.
Publicado: (2017)

Parallel multi-swarm cooperative particle swarm optimization for protein–ligand docking and virtual screening
por: Li, Chao, et al.
Publicado: (2022)

Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018)

New classes of potent heparanase inhibitors from ligand-based virtual screening
por: Pala, Daniele, et al.
Publicado: (2020)

Development of Advanced Macrosphelides: Potent Anticancer Agents
por: Paek, Seung-Mann
Publicado: (2015)

Structure based virtual screening of anticanerous polyphenolic phytocompounds against G-protein coupled receptor and identification of potent antagonist ligand(s) through molecular docking
por: Pitchai, Daisy, et al.
Publicado: (2011)

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies
por: Khalifa, Mohamed M., et al.
Publicado: (2021)

Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity
por: Chen, Qi-Yin, et al.
Publicado: (2014)

Molecular Docking Compounds of Cinnamaldehyde Derivatives as Anticancer Agents
por: Warsito, Warsito, et al.
Publicado: (2021)

New Mild and Simple Approach to Isothiocyanates: A Class of Potent Anticancer Agents
por: Luo, Bingling, et al.
Publicado: (2017)

Tropinone-Derived Alkaloids as Potent Anticancer Agents: Synthesis, Tyrosinase Inhibition, Mechanism of Action, DFT Calculation, and Molecular Docking Studies
por: Piechowska, Katarzyna, et al.
Publicado: (2020)

Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents
por: Voggu, Ramakrishna, et al.
Publicado: (2023)

Comprehensive Review on Betulin as a Potent Anticancer Agent
por: Król, Sylwia Katarzyna, et al.
Publicado: (2015)

CoDock-Ligand: combined template-based docking and CNN-based scoring in ligand binding prediction
por: Pang, Mingwei, et al.
Publicado: (2023)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents
por: Che, Tong, et al.
Publicado: (2018)

Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches
por: Bakal, Ravindra L., et al.
Publicado: (2022)

Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
por: Hori, Kiminori, et al.
Publicado: (2018)

Docking-based virtual screening of TβR1 inhibitors: evaluation of pose prediction and scoring functions
por: Wang, Shuai, et al.
Publicado: (2020)

Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents
por: Wang, Jiawen, et al.
Publicado: (2019)

Engineered Bacteriophage T7 as a Potent Anticancer Agent in vivo
por: Hwang, Yoon Jung, et al.
Publicado: (2020)

New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents
por: Dawood, Dina H., et al.
Publicado: (2021)

Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning
por: Jaradat, Nour Jamal, et al.
Publicado: (2023)

Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents
por: Xin, Ya-Bing, et al.
Publicado: (2018)

New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells
por: Tandon, Manuj, et al.
Publicado: (2013)

Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
por: Zayed, Mohamed F., et al.
Publicado: (2018)

An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
por: Zhong, Hai-Jing, et al.
Publicado: (2015)

Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents
por: Buckley, McKenna E., et al.
Publicado: (2023)

Pharmacophore feature-based virtual screening for finding potent GSK-3 inhibitors using molecular docking and dynamics simulations
por: Chauhan, Navneet, et al.
Publicado: (2016)

Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2018)

Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents
por: Porchia, Marina, et al.
Publicado: (2020)

Transition metal complexes of triazole-based bioactive ligands: synthesis, spectral characterization, antimicrobial, anticancer and molecular docking studies
por: Deswal, Yogesh, et al.
Publicado: (2021)

Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening
por: Chen, Ya, et al.
Publicado: (2018)

Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors
por: Zou, Yiquan, et al.
Publicado: (2013)

Designing metal chelates of halogenated sulfonamide Schiff bases as potent nonplatinum anticancer drugs using spectroscopic, molecular docking and biological studies
por: Elsamra, Rehab M. I., et al.
Publicado: (2022)

The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
por: Kim, Jun-Tae, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_366a8tmpp4b12oaibogb7rpoe5